Previous Article | Next Article ![]()
Infection and Immunity, June 2005, p. 3803-3805, Vol. 73, No. 6
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.6.3803-3805.2005
Atsushi Ihata, and
Dennis M. Klinman*
CBER/FDA, Bethesda, Maryland 20892
Received 18 August 2004/ Returned for modification 13 September 2004/ Accepted 10 November 2004
Immunostimulatory CpG oligodeoxynucleotides (ODN) improve host resistance to listeriae. CpG ODN trigger immune cells to produce gamma interferon and "prime" host cells to secrete nitric oxide in response to bacterial exposure. CpG treatment does not protect inducible nitric oxide synthase 2 knockout mice, indicating that NO is critical to CpG-mediated protection against listeriae.
Present address: RIMO, Osaka University, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|